Creative Medical Technology Holdings Inc Stock Ownership - Who owns Creative Medical Technology Holdings?

Insider buying vs selling

Have Creative Medical Technology Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CELZ insiders and whales buy or sell their stock.

CELZ Shareholders

What type of owners hold Creative Medical Technology Holdings Inc stock?
Timothy Warbington2.59%34,904$123.56kInsider
Michael H. Finger1.37%18,502$65.50kInsider
Vanguard Group Inc1.31%17,632$62.42kInstitution
Aaron Wealth Advisors LLC1.22%16,400$58.06kInstitution
Virtu Financial LLC1.21%16,374$57.96kInstitution
Two Sigma Investments LP1.11%14,898$52.74kInstitution
Hrt Financial LP0.98%13,194$46.71kInstitution
Two Sigma Advisers LP0.87%11,744$41.57kInstitution
Omers Administration Corp0.82%11,000$38.94kInstitution
Ubs Group Ag0.23%3,064$10.85kInstitution

1 of 2

CELZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCSA2.78%97.22%Net Buying
OGEN0.47%99.53%Net Selling

Creative Medical Technology Holdings Stock Ownership FAQ

Who owns Creative Medical Technology Holdings?

Creative Medical Technology Holdings (NASDAQ: CELZ) is owned by 7.87% institutional shareholders, 3.96% Creative Medical Technology Holdings insiders, and 88.17% retail investors. Timothy Warbington is the largest individual Creative Medical Technology Holdings shareholder, owning 34,904.00 shares representing 2.59% of the company. Timothy Warbington's Creative Medical Technology Holdings shares are currently valued at $127.92k.

If you're new to stock investing, here's how to buy Creative Medical Technology Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.